Biotech company
BioVersys has raised €61M across 5 funding rounds from 1 investor, most recently a round in Jan 2023. Based in Basel, Switzerland; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-01-05 | Other | €8.5M | The AMR Action Fund | View deal → |
| 2022-06-08 | Series C | €23M | — | View deal → |
| 2020-09-01 | Series B | €18M | — | View deal → |
| 2019-04-01 | Series A | €7.0M | — | View deal → |
| 2017-04-01 | Other | €4.7M | — | View deal → |
